发明名称 Pharmaceutical composition
摘要 The following are claimed: (1) a form of nizatidine which contains N,N`-bis(2-(2-dimethylaminomethyl-4-thiazolylmethylthio)ethyl)-2-nitro-1, 1-ethenediamine (I) and N, N`-dimethyl-2-nitro-1, 1-ethenediamine (II) but not N-methyl-1-methylthio-2-nitro-ethyleneamine (III); (2) a process for preparing a form of nizatidine, comprising heating nizatidine contg. (III) in the presence of water to remove (III); (3) the form of nizatidine produced by the process of (2); (4) a pharmaceutical compsn. contg. nizatidine which has been heated in the presence of water to remove (III); and (5) a pharmaceutical compsn. contg. nizatidine in the form of (1). Nizatidine is N-(2-(2- dimethylaminomethyl-4- thiazolylmethylthio)ethyl)-N`-methyl-2-nitro-1, 1-ethenediamine.
申请公布号 ZA9507281(B) 申请公布日期 1997.02.28
申请号 ZA19950007281 申请日期 1995.08.30
申请人 ELI LILLY AND COMPANY 发明人 MARY KAY MCCAULEY LYN;KENNETH PHILIP MODER;JEFFREY LYNN SPEAKMAN
分类号 A61K31/04;A61K9/08;A61K9/46;A61K31/13;A61K31/425;A61K31/426;A61P1/04;C07D277/26;C07D277/28 主分类号 A61K31/04
代理机构 代理人
主权项
地址